| 
Citations
 | 
   web
Momeny, M., Moghaddaskho, F., Gortany, N. K., Yousefi, H., Sabourinejad, Z., Zarrinrad, G., et al. (2017). Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cells. Sci Rep, 7, 44075.
toggle visibility
Celiku, O., Tandle, A., Chung, J. - Y., Hewitt, S. M., Camphausen, K., & Shankavaram, U. (2017). Computational analysis of the mesenchymal signature landscape in gliomas. BMC Med Genomics, 10(1), 13.
toggle visibility
Jensen, S. S., Petterson, S. A., Halle, B., Aaberg-Jessen, C., & Kristensen, B. W. (2017). Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo. BMC Cancer, 17(1), 178.
toggle visibility
Brown, D. V., Filiz, G., Daniel, P. M., Hollande, F., Dworkin, S., Amiridis, S., et al. (2017). Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity. PLoS One, 12(2), e0172791.
toggle visibility
Ludwig, K., & Kornblum, H. I. (2017). Molecular markers in glioma. J Neurooncol, .
toggle visibility